DE3224619A1 - Orale pharmazeutische zusammensetzung - Google Patents

Orale pharmazeutische zusammensetzung

Info

Publication number
DE3224619A1
DE3224619A1 DE19823224619 DE3224619A DE3224619A1 DE 3224619 A1 DE3224619 A1 DE 3224619A1 DE 19823224619 DE19823224619 DE 19823224619 DE 3224619 A DE3224619 A DE 3224619A DE 3224619 A1 DE3224619 A1 DE 3224619A1
Authority
DE
Germany
Prior art keywords
drug
water
composition according
fatty acid
unsaturated fatty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19823224619
Other languages
German (de)
English (en)
Other versions
DE3224619C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html
Inventor
Akira Tokushima Akazawa
Emiko Urawa Saitama Kudo
Shimesu Asaka Saitama Motoyama
Satoshi Higashi Saitama Sato
Takuichi Tokyo Tsujino
Seiichi Sakado Saitama Umeda
Hirotsune Matsudo Saitama Yasumi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Freund Corp
Original Assignee
Freund Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP10977781A external-priority patent/JPS5813508A/ja
Priority claimed from JP17516881A external-priority patent/JPS5877810A/ja
Application filed by Freund Corp filed Critical Freund Corp
Publication of DE3224619A1 publication Critical patent/DE3224619A1/de
Application granted granted Critical
Publication of DE3224619C2 publication Critical patent/DE3224619C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE19823224619 1981-07-14 1982-07-01 Orale pharmazeutische zusammensetzung Granted DE3224619A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10977781A JPS5813508A (ja) 1981-07-14 1981-07-14 ポリグリセロール飽和脂肪酸エステルを含む経口薬剤組成物
JP17516881A JPS5877810A (ja) 1981-11-01 1981-11-01 ポリグリセロ−ル不飽和脂肪酸エステルを含む経口薬剤組成物

Publications (2)

Publication Number Publication Date
DE3224619A1 true DE3224619A1 (de) 1983-05-19
DE3224619C2 DE3224619C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-10-04

Family

ID=26449492

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19823224619 Granted DE3224619A1 (de) 1981-07-14 1982-07-01 Orale pharmazeutische zusammensetzung

Country Status (4)

Country Link
US (1) US4751241A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880000970B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH652307A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3224619A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988000059A1 (en) * 1986-07-01 1988-01-14 Drilletten Ab A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
EP0368247A3 (en) * 1988-11-08 1991-05-08 Takeda Chemical Industries, Ltd. Controlled release preparations
EP0455391A3 (en) * 1990-04-28 1991-12-18 Takeda Chemical Industries, Ltd. Granulated preparations and method of producing the same
US5179122A (en) * 1991-02-11 1993-01-12 Eastman Kodak Company Nutritional supplement containing vitamin e
US5229164A (en) * 1985-12-19 1993-07-20 Capsoid Pharma Gmbh Process for producing individually dosed administration forms
US5399357A (en) * 1988-11-08 1995-03-21 Takeda Chemical Industries, Ltd. Sustained release preparations
EP0598337A3 (en) * 1992-11-13 1995-06-14 Vectorpharma Int Medicinal compositions containing a drug, a cross-linked polymer, an oil, and a surfactant.
DE19722405A1 (de) * 1997-05-28 1998-12-03 Ifac Inst Fuer Angewandte Coll Einkapseln von wasserunlöslichen Wirkstoffen mit amphiphilem Charakter
WO2000023069A1 (en) * 1998-10-21 2000-04-27 Sigma-Tau Healthscience S.P.A. Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using same
WO2003007907A1 (de) * 2001-07-12 2003-01-30 Aquanova German Solubilisate Technologies (Agt) Gmbh Wasserfreies ubichinon-konzentrat

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3588023D1 (de) * 1984-01-28 1995-06-29 Roshdy Ismail Mittel zur Behandlung von Herzerkrankungen.
US5656620A (en) * 1984-01-28 1997-08-12 Ismail; Roshdy Method for treating pain
JP2643217B2 (ja) * 1988-01-22 1997-08-20 エーザイ株式会社 脂溶性物質水性液
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
DK0484529T3 (da) * 1989-08-03 1994-05-30 Hisamitsu Pharmaceutical Co Hudcremepræparat til udvortes brug
DE69324523T2 (de) * 1992-06-12 1999-09-09 Kao Corp. Badezusatzzusammensetzung enthaltend oberflächenaktive Mittel enthaltende nahtlose Kapsel und Verfahren zur Herrstellung der Kapsel
AU5832794A (en) * 1993-01-06 1994-08-15 T.S. Consult Aps Medium comprising a pharmacological/biological active substance
DE19647352C2 (de) * 1996-11-15 2000-06-29 Aqua Nova Getraenketechnologie Nicht alkoholisches Getränk mit einem Gehalt an Q 10
WO1999022719A1 (fr) * 1997-10-30 1999-05-14 Morishita Jintan Co., Ltd. Preparation de capsule contenant un acide gras insature ou un derive de celui-ci, et procede de fabrication
ATE462417T1 (de) 1998-08-13 2010-04-15 Cima Labs Inc Microemulsionen als feste dosisformen zur oralen verabreichung
AP2002002552A0 (en) 1999-12-23 2002-06-30 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations.
US6692771B2 (en) 2001-02-23 2004-02-17 Cima Labs Inc. Emulsions as solid dosage forms for oral administration
JP3549197B2 (ja) * 2001-08-10 2004-08-04 日清ファルマ株式会社 ユビキノン含有製剤
TW200302056A (en) * 2002-01-18 2003-08-01 Kaneka Corp Method for stabilizing reduced coenzyme Q10 and composition therefor
WO2004064543A1 (ja) * 2003-01-17 2004-08-05 Taiyo Kagaku Co., Ltd. コエンザイムq10含有組成物
ES2496102T3 (es) * 2003-03-28 2014-09-18 Sigmoid Pharma Limited Forma de dosificación oral sólida que contiene microcápsulas sin fisuras
ES2401185T3 (es) * 2004-09-27 2013-04-17 Sigmoid Pharma Limited Formulaciones de microcápsulas que comprenden dos ingredientes farmacéuticamente activos
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
JP5399072B2 (ja) 2005-09-12 2014-01-29 アベラ ファーマスーティカルズ インコーポレイテッド ジメチルスルホキシド（ｄｍｓｏ）若しくは関連化合物、又はそれに関連する臭気を除去するシステム
US8480797B2 (en) 2005-09-12 2013-07-09 Abela Pharmaceuticals, Inc. Activated carbon systems for facilitating use of dimethyl sulfoxide (DMSO) by removal of same, related compounds, or associated odors
US9427419B2 (en) 2005-09-12 2016-08-30 Abela Pharmaceuticals, Inc. Compositions comprising dimethyl sulfoxide (DMSO)
US8506956B2 (en) * 2005-10-31 2013-08-13 Kaneka Corporation Method for stabilizing reduced coenzyme Q10
JP5128801B2 (ja) * 2006-10-16 2013-01-23 フロイント産業株式会社 高水分散性粉末とその製造方法
US8911777B2 (en) * 2007-04-04 2014-12-16 Sigmoid Pharma Limited Pharmaceutical composition of tacrolimus
CA2685118C (en) * 2007-04-26 2016-11-01 Sigmoid Pharma Limited Manufacture of multiple minicapsules
WO2008132712A2 (en) * 2007-05-01 2008-11-06 Sigmoid Pharma Limited Combination pharmaceutical compositions
EP2172223B1 (en) * 2007-06-22 2020-12-16 Kaneka Corporation Composition containing physiologically active substance
US20110123505A1 (en) * 2007-08-22 2011-05-26 Kaneka Corporation Method of producing reduced coenzyme q10 and method of stabilizing the same
WO2009025372A1 (ja) * 2007-08-23 2009-02-26 Kaneka Corporation 還元型補酵素ｑ１０含有組成物及びその安定化方法
BRPI0921494A2 (pt) * 2008-11-03 2018-10-30 Prad Reasearch And Development Ltd método de planejamento de uma operação de amostragem para uma formação subterrãnea, método de contolar uma operação de amostragem de formação subterrânea, método de controlar uma operação de perfuração para uma formação subterrãnea, e método de realizar uma amostragem durante a operação de perfuração.
GB2483815B (en) 2009-05-18 2013-12-25 Sigmoid Pharma Ltd Composition comprising oil drops
IN2012DN00781A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 2009-08-12 2015-06-26 Sigmoid Pharma Ltd
EP2493314B1 (en) 2009-10-30 2020-04-08 Abela Pharmaceuticals, Inc. Dimethyl sulfoxide (dmso) and methylsulfonylmethane (msm) formulations to treat osteoarthritis
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
AU2015217651A1 (en) * 2014-02-13 2016-09-01 Clariant International Ltd. Preparation of polyglycerols
HUE053624T2 (hu) 2014-11-07 2021-07-28 Sublimity Therapeutics Ltd Ciklosporint tartalmazó készítmények
JP7560982B2 (ja) * 2020-09-18 2024-10-03 日清ファルマ株式会社 コエンザイムｑ１０含有水溶性組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079138A (en) * 1975-01-02 1978-03-14 American Home Products Corporation Permanent suspension pharmaceutical dosage forms
GB2015339A (en) * 1978-03-07 1979-09-12 Sandoz Ltd Compositions comprising mono-cyclic peptides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932634A (en) * 1973-06-28 1976-01-13 Pfizer Inc. High potency vitamin water dispersible formulations
US3966632A (en) * 1974-06-06 1976-06-29 G. D. Searle & Co. Vegetable oil emulsion
US4073943A (en) * 1974-09-11 1978-02-14 Apoteksvarucentralen Vitrum Ab Method of enhancing the administration of pharmalogically active agents
JPS574916A (en) * 1980-05-28 1982-01-11 Furointo Sangyo Kk Activation of medical preparation
US4327076A (en) * 1980-11-17 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same
US4327077A (en) * 1981-05-29 1982-04-27 Life Savers, Inc. Compressed chewable antacid tablet and method for forming same

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4079138A (en) * 1975-01-02 1978-03-14 American Home Products Corporation Permanent suspension pharmaceutical dosage forms
US4079131A (en) * 1975-01-02 1978-03-14 American Home Products Corporation Permanent suspension pharmaceutical dosage forms
US4079128A (en) * 1975-01-02 1978-03-14 American Home Products Corporation Permanent suspension pharmaceutical dosage forms
US4079132A (en) * 1975-01-02 1978-03-14 American Home Products Corporation Permanent suspension pharmaceutical dosage forms
GB2015339A (en) * 1978-03-07 1979-09-12 Sandoz Ltd Compositions comprising mono-cyclic peptides

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5229164A (en) * 1985-12-19 1993-07-20 Capsoid Pharma Gmbh Process for producing individually dosed administration forms
WO1988000059A1 (en) * 1986-07-01 1988-01-14 Drilletten Ab A controlled-release composition for a biologically active material dissolved or dispersed in an l2-phase
US5593690A (en) * 1988-11-08 1997-01-14 Takeda Chemical Industries, Ltd. Sustained release preparations
EP0368247A3 (en) * 1988-11-08 1991-05-08 Takeda Chemical Industries, Ltd. Controlled release preparations
US5399357A (en) * 1988-11-08 1995-03-21 Takeda Chemical Industries, Ltd. Sustained release preparations
EP0455391A3 (en) * 1990-04-28 1991-12-18 Takeda Chemical Industries, Ltd. Granulated preparations and method of producing the same
US5179122A (en) * 1991-02-11 1993-01-12 Eastman Kodak Company Nutritional supplement containing vitamin e
EP0598337A3 (en) * 1992-11-13 1995-06-14 Vectorpharma Int Medicinal compositions containing a drug, a cross-linked polymer, an oil, and a surfactant.
DE19722405A1 (de) * 1997-05-28 1998-12-03 Ifac Inst Fuer Angewandte Coll Einkapseln von wasserunlöslichen Wirkstoffen mit amphiphilem Charakter
WO1998053797A3 (de) * 1997-05-28 1999-03-11 Ifac Inst Fuer Angewandte Coll Einkapseln von wasserunlöslichen wirkstoffen mit amphiphilem charakter
WO2000023069A1 (en) * 1998-10-21 2000-04-27 Sigma-Tau Healthscience S.P.A. Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiquinones and methods of using same
US6417233B1 (en) 1998-10-21 2002-07-09 Sigma-Tau Healthscience S.P.A. Ubiguinone-containing composition suitable for promoting enhanced intramitochondrial transportation of ubiguinones and methods of using same
WO2003007907A1 (de) * 2001-07-12 2003-01-30 Aquanova German Solubilisate Technologies (Agt) Gmbh Wasserfreies ubichinon-konzentrat
US7094804B2 (en) 2001-07-12 2006-08-22 Aquanova German Solubilisate Technologies Water free ubiquinone concentrate

Also Published As

Publication number Publication date
KR840000233A (ko) 1984-02-18
US4751241A (en) 1988-06-14
KR880000970B1 (ko) 1988-06-07
CH652307A5 (de) 1985-11-15
DE3224619C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1990-10-04

Similar Documents

Publication Publication Date Title
DE3224619A1 (de) Orale pharmazeutische zusammensetzung
DE69526655T2 (de) Wässrige emulsion mit kontrollierter freisetzung
EP0178436B1 (de) Ibuprofen enthaltende Weichgelatinekapseln und Verfahren zu ihrer Herstellung
DE69524953T2 (de) Antibakterielle öl-in-wasser-emulsion
AT408945B (de) Orale pharmazeutische zubereitung
EP0277459B1 (de) Arzneimittel mit verzögerter Wirkstofffreisetzung
DE2601207C3 (de) Verfahren zur Herstellung einer flüssigen pharmazeutischen Zubereitung mit gesteuertem Arzneimittelabgabevermögen
DE3853191T2 (de) Arzneimittelträger.
DE69206245T2 (de) Rifaximin enthaltendes Arzneimittel zur Behandlung von Vaginalinfektionen.
DE60018372T2 (de) Oralzusammensetzung als mikroemulsion von silybin
DE68917544T2 (de) Durchsichtiges Präparat.
DE3013839A1 (de) Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
EP0616801A1 (de) Verfahren zur Herstellung einer Liposomendispersion im Hochdruckbereich
DE69119400T2 (de) System auf basis einer lipidformulierung
EP0711557A1 (de) Pharmazeutische Formulierungsgrundlage
EP3908253B1 (de) Oraler dünnfilm
EP1249230B1 (de) Coenzym Q10 enthaltende Mikroemulsion-Prekonzentrate und Mikroemulsionen
DE69921919T2 (de) Sterolester in tablettierter fester Arzneiform
EP0945136B1 (de) Topisches Arzneimittel mit einem Gehalt an Ciclosporin
DE69525740T2 (de) Spezielle halofantrinhaltige Zusammensetzungen
DE4038385C2 (de) Sitosterol und seine Glykoside mit verbesserter Bioverfügbarkeit
DE2201357C2 (de) Osmotische Wirkstoffabgabevorrichtung
DE69232940T2 (de) Vesiculae in nichtpolaren Medien
DE60006000T2 (de) Pharmazeutische zusammensetzungen zur oralen verabreichung
DE2163538C3 (de) Verfahren zur Herstellung wäßriger Suspensionen von Chloramphenicol-palmitat

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8363 Opposition against the patent
8331 Complete revocation